日本語English简体中文 繁體中文

4582 SymBio Pharmaceuticals Limitedシンバイオ製薬TSE Growth / Pharmaceuticals

0 posts

SymBio Pharmaceuticals Limited stock plunged on Nov 20: what happened

It closed at ¥69.0 on Nov 20 (−¥9.0, −11.54%), ranking #39 among the top losers of all stocks on the Tokyo Stock Exchange.

No disclosures were found for this stock around that day. Share what you know in the posts below.

Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.

SymBio Pharmaceuticals Limited (4582) at a glance

Code
4582
Company
SymBio Pharmaceuticals Limited
Local name
シンバイオ製薬
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥69.0 -9.00 (-11.54%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

SymBio Pharmaceuticals Limited (4582) Stock Price History

SymBio Pharmaceuticals Limited closed at ¥69.0 on Nov 20, 2026, +40.8% over 1 month, −33.0% over 1 year.

2026-10-29 2026年12月期第3四半期決算短信〔日本基準〕(連結)2026-11-06 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の 大量行使に関…2026-11-09 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の大量行使に関…¥78.0¥42.0Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥78.0Nov 19
1-Month Low¥42.0Nov 4
1-Week Change+16.9%vs Nov 13
1-Month Change+40.8%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥140,816 today (+40.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved +40.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥69.0−9−11.54%
Nov 19 (Thu)¥78.0+7+9.86%
Nov 18 (Wed)¥71.0−4−5.33%
Nov 17 (Tue)¥75.0+11+17.19%
Nov 16 (Mon)¥64.0+5+8.47%
Nov 13 (Fri)¥59.0+7+13.46%
Nov 12 (Thu)¥52.0−4−7.14%
Nov 10 (Tue)¥56.0−12−17.65%
Nov 6 (Fri)¥68.0−4−5.56%
Nov 5 (Thu)¥72.0+30+71.43%
2026-10-29 2026年12月期第3四半期決算短信〔日本基準〕(連結)2026-11-06 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の 大量行使に関…2026-11-09 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の大量行使に関…¥78.0¥42.0Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥78.0Nov 19
3-Month Low¥42.0Nov 4
1-Month Change+40.8%vs Oct 20
3-Month Change+4.5%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥104,545 today (+4.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved +4.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥69.0−9−11.54%
Nov 19 (Thu)¥78.0+7+9.86%
Nov 18 (Wed)¥71.0−4−5.33%
Nov 17 (Tue)¥75.0+11+17.19%
Nov 16 (Mon)¥64.0+5+8.47%
Nov 13 (Fri)¥59.0+7+13.46%
Nov 12 (Thu)¥52.0−4−7.14%
Nov 10 (Tue)¥56.0−12−17.65%
Nov 6 (Fri)¥68.0−4−5.56%
Nov 5 (Thu)¥72.0+30+71.43%
2026-10-29 2026年12月期第3四半期決算短信〔日本基準〕(連結)2026-11-06 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の 大量行使に関…2026-11-09 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の大量行使に関…¥83.0¥42.0May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥83.0May 22
6-Month Low¥42.0Nov 4
3-Month Change+4.5%vs Aug 20
6-Month Change−15.9%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥84,146 today (−15.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −15.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥69.0+56.8%
Oct 2026¥44.0−21.4%
Sep 2026¥56.0−12.5%
Aug 2026¥64.0−7.2%
Jul 2026¥69.0+0.0%
Jun 2026¥69.0−12.7%
May 2026¥79.0−14.1%
2026-10-29 2026年12月期第3四半期決算短信〔日本基準〕(連結)2026-11-06 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の 大量行使に関…2026-11-09 第三者割当により発行された第70回新株予約権(行使価額修正条項付)の大量行使に関…¥201¥42.0Nov 21Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥201Feb 24
52-Week Low¥42.0Nov 4
Year to Date−23.3%vs Dec 26
From 52-Week High−65.7%Feb 24

If you had invested ¥100,000 1 year ago, it would be worth ¥65,714 today (−34.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +16.1%, while this stock moved −34.3%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥69.0+56.8%
Oct 2026¥44.0−21.4%
Sep 2026¥56.0−12.5%
Aug 2026¥64.0−7.2%
Jul 2026¥69.0+0.0%
Jun 2026¥69.0−12.7%
May 2026¥79.0−14.1%
Apr 2026¥92.0−17.9%
Mar 2026¥112−30.9%
Feb 2026¥162+88.4%
Jan 2026¥86.0−4.4%
Dec 2025¥90.0−15.9%
Nov 2025¥107―
¥370¥44.0Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥370Jul 15, 2024
3-Year Low¥44.0Oct 30, 2026
Annualized Return−36.1%
Max Drawdown−88.1%

If you had invested ¥100,000 3 years ago, it would be worth ¥26,136 today (−73.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −73.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥69.0−23.3%
2025¥90.0―
¥1,477¥44.0Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥1,477Nov 22, 2021
5-Year Low¥44.0Oct 30, 2026
Annualized Return−45.9%
Max Drawdown−97.0%

If you had invested ¥100,000 5 years ago, it would be worth ¥4,672 today (−95.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −95.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥69.0−23.3%
2025¥90.0―
¥3,356¥44.0Nov 1, 2011Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥3,356Apr 2013
All-Time Low¥44.0Oct 2026
Total Change−93.1%vs Nov 2011
Annualized Return−16.3%

If you had invested ¥100,000 in Nov 2011, it would be worth ¥6,873 today (−93.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +567.5%, while this stock moved −93.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥69.0−23.3%
2025¥90.0−54.8%
2024¥199−19.4%
2023¥247−61.6%
2022¥643−43.8%
2021¥1,145+202.1%
2020¥379−37.6%
2019¥607−20.1%
2018¥760−13.2%
2017¥876−10.2%
2016¥976+5.2%
2015¥928−35.0%
2014¥1,428−6.1%
2013¥1,520+26.7%
2012¥1,200−37.2%
2011¥1,912―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2011). Please check the latest prices before trading.

SymBio Pharmaceuticals Limited (4582) financial indicators

Dividend yield
0.00%

See all financial indicators for SymBio Pharmaceuticals Limited (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of SymBio Pharmaceuticals Limited (4582)

Business overview

Together with one consolidated subsidiary established as an overseas strategic base and others, the company runs research and development, manufacturing and sales of pharmaceuticals and related operations as a single segment. It was founded in March 2005 by 「吉田文紀」, a former corporate vice president at the headquarters of biopharmaceutical leader Amgen who served as president of its Japanese arm for about 12 years. Its management philosophy is co-creation and coexistence, and its business purpose is to connect doctors, scientists, governments and capital providers around patients to meet unmet medical needs where no effective drugs or treatments exist. Rare disease fields in oncology, hematology and viral infections require high expertise and are difficult to develop, making them hard for large pharmaceutical companies to take on for profitability and other reasons, and the company works on developing new drugs in these fields.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Market cap¥5.8 bnNo. 58 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥2012/24
52-week low¥4211/4
Current position17.0%Where the low is 0% and the high is 100% (close on 11/20: ¥69)
Year to date-23.3%No. 47 of 77 in the sector (best first)
1 year-33.0%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers4 timesLatest: 11/19 (No. 14)
Top 50 losers4 timesLatest: 11/20 (No. 39)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (8).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the SymBio Pharmaceuticals Limited board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English